What Researchers Did
Researchers evaluated the effect of normobaric hyperoxic (NBO) therapy on tissue oxygenation in 100 patients with diabetic foot ulcers.
What They Found
The study found that transcutaneous partial oxygen tension (TcPO₂) significantly increased during NBO therapy, rising from a mean of 46.6 mmHg before treatment to 88.9 mmHg during therapy (p < 0.001). After therapy, TcPO₂ returned to 49.9 mmHg, and patients with lower initial oxygen levels experienced a greater increase.
What This Means for Canadian Patients
This pilot study suggests that normobaric hyperoxic therapy could be a promising, accessible option to improve tissue oxygenation in Canadian patients with diabetic foot ulcers. If confirmed by larger studies, this therapy might help promote wound healing and potentially reduce complications associated with poor oxygenation.
Canadian Relevance
This study was not conducted in Canada and therefore has no direct Canadian connection.
Study Limitations
As a pilot study, this research was limited by its relatively small sample size and short-term observation of oxygenation changes rather than long-term clinical outcomes.